Next Article in Journal
Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms
Previous Article in Journal
Fasting-Induced Upregulation of MKP-1 Modulates the Hepatic Response to Feeding
Previous Article in Special Issue
International Latin American Survey on Pediatric Intestinal Failure Team

Latin American Considerations for Infant and Young Child Formulae

Faculty of Medicine, Research Institute on Nutrition, Genetics and Metabolism IINGM, Universidad El Bosque, Bogotá 110121, Colombia
Nutrition Working Group, Latin-American Society for Pediatric Gastroenterology Hepatology and Nutrition LASPGHAN, Mexico City 11560, Mexico
Research and Education Center on Nutrition, CIENutrition, Bogotá 110221, Colombia
Department of Gastroenterology and Nutrition, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico
Department Pediatrics, Medical Centre of LMU Munich, Ludwig Maximilians University of Munich, Dr. von Hauner Children’s Hospital, 80539 München, Germany
Author to whom correspondence should be addressed.
Academic Editor: Sheila Erin Fleischhacker
Nutrients 2021, 13(11), 3942;
Received: 6 August 2021 / Revised: 21 October 2021 / Accepted: 27 October 2021 / Published: 4 November 2021
(This article belongs to the Special Issue Nutrition Research in Latin America)


Infant formula is the only acceptable substitute for breastmilk from 0 to 6 months old when human milk cannot be provided in sufficient amounts. Manufacturers have developed options that intend to meet the changing needs of the child aged from six to twelve months (follow-on formulae) and after the age of one year (young child formulae). The international code for marketing breast milk substitute stipulates standards for marketing practices of these products. In Latin America there are local variations of marketing practices. Novel marketing strategies such as advertising through social media and influencers pose new threats for breastfeeding success in Latin America. This review aims to examine variations in local regulations for marketing of infant formulae and to analyze the emerging phenomenon of influencer advertising. We reviewed the local norms for Latin American countries and examined differences and possible gaps. Emerging evidence of influencer marketing was explored. The results indicate that national regulations differ among Latin American countries, particularly with respect to product labelling and the requirement to use a local native language, highlighting the cost of the product, and different regulations prohibiting certain messages and illustrations. Regarding new marketing strategies, there is limited evidence on advertising infant formula through social media influencers, where different categories of marketing strategies can be described. More transparent reporting of social marketing by formula providers and more independent research on novel marketing strategies are needed.
Keywords: infant formulae; follow-up formulae; young child formulae; marketing practices; national regulations; influencers infant formulae; follow-up formulae; young child formulae; marketing practices; national regulations; influencers

1. Introduction

For populations globally, the World Health Organization (WHO) recommends exclusive breastfeeding for about six months with continued breastfeeding along with balanced complementary feeding until at least two years of age, considering the benefits of breastfeeding on risk reduction for infection, physical, mental and social development [1]. For populations with a low burden of infectious disease such as infants in Europe, breastfeeding for at least the first 6 months of life and exclusive breastfeeding for 4-6 months has been recommended [2]. Infants that cannot receive sufficient amounts of human breast milk need safe infant formula of high quality as a breast milk substitute [3].
Formulae for infants are classified into regular formula for generally healthy infants, and formula for special medical purposes for the dietary management of disorders under medical supervision [4]. The regulatory standards of the Codex Alimentarius of the WHO and the Food and Agriculture Organization of the United Nations (FAO) [4], the European Food Safety Authority (EFSA) and the European Commission [5,6] and the United States Food and Drug Administration (FDA) [7] are based on the general agreement that “Infant formula means a breast-milk substitute specially manufactured to satisfy, by itself, the nutritional requirements of infants during the first months of life up to the introduction of appropriate complementary feeding”[4].
Since infant formula differs from other foods in that it must satisfy all the nutritional needs of an individual from a single food product, while providing a very high nutrient supply per kg bodyweight during a particularly sensitive and vulnerable period of life, the regulatory standards for infant formulae set much stricter compositional, quality and safety standards than for any other food products [3].
There are also additional ingredients such as nucleotides, docosahexaenoic acid (DHA), arachidonic acid (ARA), oligosaccharides with presumed prebiotic functions, probiotics and complex fat components, which are added to some formulae because they are expected to provide potential benefits on visual and brain functions, the immune and bone system, intestinal microbiota, and other outcomes [8].
Globally and in Latin America, there is a need for enhancing promotion of breastfeeding. Inappropriate marketing practices for infant formulae need to be identified and ended. The international Code for marketing of Breast milk substitutes (BMS) stipulates standards for BMS marketing, which countries have implemented with different variations into national regulations. New challenges arise due to the emergence of social media and influencer marketing of BMS that are not yet fully regulated.
This review aims to examine the characteristics of infant, follow-up and young child formulae, national differences of legal regulations for these products across different Latin American countries and to describe a current marketing strategy for BMS.

2. Methods

Within the months of March and June 2021 research of systematic reviews and intervention studies using the term “infant formula”, “infant formula composition”, “formula preparation”, “follow-up formula”, “follow-up formula composition”, “young child formula” and “young child formula composition”, “infant formula marketing”, “formula marketing” and “formula influencers” was carried out in English and Spanish language in the databases: PubMed, Elsevier and Scielo. Similarly, materials related to formula feeding, different types of formula and formula preparation provided by international entities such as WHO, CODEX Alimentarius and UNICEF United Nations children’s Fund were revised.
Additionally, the regulatory norms for BMS marketing for Latin American countries were compiled where available online or through individual experts contacted in the respective countries.

3. Infant Formulae

The global standards for infant formula composition were revised by the Codex Alimentarius in 2007 [4] and were informed by recommendations of an international expert group invited by the European Society of Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), published in 2005, which are presented in Table 1.
Infant formula is required to provide a protein content in the range of 1.8–3.0 g/100 kcal (7.3–12% of energy) if based on cows’ or goats’ milk protein [4,6] or a higher protein content if based on soy protein isolate. A minimum content of indispensable amino acids is defined. While cows’ milk usually provides about 70–80% of casein and 20–30% whey proteins, modern formulae are enriched with whey proteins to improve the amino acid supply.
More than a decade ago, the early protein hypothesis was established suggesting that a high protein intake in excess of infant requirements can promote early weight gain (i.e., a rapid increase in infant weight), an increased later obesity risk, along with elevating insulinogenic amino acids, insulin release and insulin-like growth factor 1 (IGF-1) in infant blood and tissues [10]. This hypothesis has been confirmed with the results of the European CHOP (Childhood Obesity Project) randomized trial. Infants were randomized to feeding with a conventional formula with a high protein content, or an isoenergetic formula with a reduced protein content closer to human milk composition [11]. Infant feeding of the higher protein formula resulted in a significantly higher BMI (Body Mass Index) and body fat mass at the ages of 2 and 6 years, and a 2.6 fold higher obesity risk at age 6 years after adjusting for confounders, compared to infant feeding with the lower protein formula [11]. Accordingly, EFSA and the European Commission reduced the range of acceptable protein content in formula for infants, and also the new Codex Alimentarius draft standard for follow-on formula suggests a lower range of acceptable protein content.
Carbohydrates in infant formula usually are in the range of 9–14 g/100 kcal (36–56% of energy) [4,6]. The preferred carbohydrate in infant formulae is lactose, the only digestible carbohydrate in human milk. Lactose has prebiotic effects and benefits for the gut microbiome, intestinal physiology and calcium absorption [12,13].
The fat content and composition in human milk is very variable and is modified by the mother’s diet and other factors [14]. Formula fat composition is very different from human milk fat. Formula fat is usually based on a mix of vegetable oils such as canola, soy, sunflower, palm and coconut oils that are emulsified with soy lecithin. The addition of the long-chain polyunsaturated fatty acids docosahexaenoic acid (DHA) and arachidonic acid (ARA) to infant and follow-on formula is recommended [15]. Table 2 provides a summary of the macronutrient content of infant formulae in 100 mL of a standard dilution and per 100 kcal as stipulated by current regulatory standards.
For the Nutrition Group of the Latin American Society of Pediatric Gastroenterology, Hepatology and Nutrition (LASPGHAN), infant formulae are the only advisable BMS. Infant formula may be fed for the whole first year and beyond.

4. Follow-Up Formulae

Even though infant formulae are suitable for the feeding for the duration of the first year of life and beyond, follow-on formulae have been offered since the 1970ies and are now widely used around the world to enable an adaptation of dietary intake to age related changes in needs [16]. According to the Codex Alimentarius, follow-up formula is: “a food intended for use as a liquid part of the weaning diet for the infant from the 6th month on and for young children” [17]. In the European food legislation, the compositional requirements for infant and follow-up formula are very similar. The major differences of follow-up formula composition, as compared to infant formula, are an increased iron content (0.5–2.0 vs. 0.3–1.3 mg/100 kcal) and a lower minimum protein content (1.6 vs. 1.8 g/100 kcal), matching the changing requirements over time [6,18]. High iron stores at birth suffice to cover the iron needs for growth during the first postnatal month, compensating for the low iron content of human milk, and they lead to a low postnatal iron absorption. Therefore, a high iron supply with formula in the first 6 months remains mostly unabsorbed and the non-absorbed iron can induce adverse effects on gut microbiota, infection and inflammation, and length growth. Therefore, a low iron supply with formula fed from birth, similar to the low iron supply with breastfeeding, is desirable. However, towards the end of the first year endogenous iron stores become depleted, and an increased dietary iron supply from complementary feed and higher contents in follow-up formula is useful.
Infant protein requirements are related to weight gain velocity which rapidly declines during the first months of life. Accordingly, protein requirements per kg bodyweight at 6 months of age are only 2/3 of those after birth, and protein supply per kg bodyweight in an exclusively breastfed infant at 6 months is only 55% of that after birth [19]. The use of adequately composed follow-up formula can help to better match dietary intake to changing needs with age. LASPGHAN suggests that they can be used for infants older than 6 months without age limit. Lactose should continue to be the main carbohydrate, whereas they should be sucrose free.
Global standards for the follow-up formulae composition were updated by the Codex Alimentarius in 2013 and are currently under review [17]. They were informed by recommendations of international experts coordinated by the Early Nutrition Academy (ENA) [20] (Table 3 provides a summary of the micronutrient content of infant formulae in 100 mL of a standard dilution and per 100 kcal as stipulated by current regulatory standards.

5. Young Child Formula

While infant and follow-up formulae serve as a substitute for breast milk, young child formulae used from the age of one year onwards are meant to serve as an alternative to cows’ milk with an improved nutrient composition. Manufacturers have often called such products “growing up milks”, a term that is not supported by the pediatric community because it implies that such products would have a functional impact on growth for which there is no evidence whatsoever, therefore the term “growing up milks” is considered an unfounded and misleading health claim. The protein content of young child formula is usually lower than that of cows’ milk (CM). Fats are mostly a blend of vegetable oils similar to other regular formulae, and hence they contain more polyunsaturated and less saturated fats than cows’ milk. Many products contain not only lactose but are also sweetened with saccharose (sucrose), which is undesirable. Moreover, the frequent addition of strong flavors and aromas is not supported because it may interfere with the desirable imprinting of taste preferences for normal healthy foods. Given that young children around the world [21] as well as in Europe [22] often have insufficient intakes of critical nutrients such as iodine, iron, vitamin D, alpha-linolenic acid and DHA and too high intakes of animal protein, adequately composed young child formula are one of several options that can contribute to improve dietary quality [21,23]. Recommendations for the composition of young child formula have been published (Table 4).
Across Latin American countries nutritional deficiencies of iron, zinc, vitamin A, vitamin D and other nutrients have been reported with a high prevalence in different Nutrition Surveys of most of the countries in the region. In 2016, UNICEF reported that only 16% of children between 6 and 23 months of age in the world complied with the minimum acceptable diet, defined as those who reach the minimum number of meals plus a minimum number of foods on the previous day [24]. LASPGHAN considers that in the case of Latin America, adequately composed young child formulae replacing part of the dietary CM may have additional benefits for children who have a poor diet [22].
Figure 1 summarizes the average energy content of the regular formulae marketed for different age groups, the minimum protein content for infant formulae, follow-up formulae and young child formulae, based on the different requirements available for their composition [4,17,23].

6. Presentation, Storage and Preparation of Formulae

Formulae for infants and young children are marketed as powder, ready-to-use formula, or concentrated liquid formula. All have a similar nutritional content, but specifications for preparation, storage and use differ [25].
Powdered formulae should be prepared by diluting the product in warm water. It is essential to use clean potable water, not contaminated with microorganisms, high nitrate contents, or untoward concentrations of trace elements such as fluoride, copper, lead or arsenic. The use of bottled water is recommended when no other source of safe water is available [26]. Families should follow the manufacturer’s specific instructions; they must use the measure or scoop and avoid the use of kitchen utensils or the measure of other products since the correct preparation depends on this [8]. Within the first months of life, it is recommended to provide the formula at a warm temperature. To achieve this, it can be heated in a water bath for 5 to 10 min before offering it. A microwave oven should never be used to heat the formula as this creates the risk of burns caused by “hot spots” in the dilution, which are not detectable when the mother performs the temperature test on her wrist. Regarding storage of formula powder, it is recommended to keep the container in a dark, cool and ventilated place but not in the refrigerator [8]. It is key to instruct parents in proper hygiene practices such as hand washing and the importance of using a clean surface and utensils (containers and bottles) during the preparation and feeding process. It has been found that a large number of parents use improper preparation techniques by not following the manufacturer’s recommendations, such as the order of adding the ingredients. The FAO and WHO recommend that powdered infant formulae should be prepared by first adding the water and then the powder to be able to reconstitute a greater volume than that given merely by water [27]. This extra volume is given by the displacement and hydration of the powder. If not done properly, there can be a change in the energy density of the formula, which may affect the infant’s energy and nutrient intake [28], and it can increase renal solutes load, alter weight gain, cause gastrointestinal discomfort, and even lead to osmotic diarrhea. All of the above, often cause an unnecessary change of the formula, as well as an increase in costs to the health system in the event that this happens at the intra-hospital level or to higher parents and/or caregivers expenses [29].
Table 5 shows the final volume of properly prepared infant formulae.
Prepared formula is a good growth medium for pathogenic microorganisms that may occur in small numbers in the powder and in the surrounding environment when preparing formula, for example Salmonella spp. or Cronobacter spp. If these are sufficiently multiplied in formula after reconstitution they may cause invasive infections, particularly in preterm and term neonates [31]. Therefore, powdered formula should always be freshly prepared for each feed and be fed within a period of 2 h after preparation, while unused prepared formula should be discarded [3]. Hospitals, day care centres and other institutions should follow strict hygienic standards and written guidelines for the preparation and handling of formula. For neonatal wards, the use of liquid formula is encouraged if feasible and affordable.

7. Marketing of Formulae for Infants and Young Children

The global paediatric community is a strong supporter of the International Code of Marketing of Breastmilk Substitutes (“Code of Marketing”) and its goals to eliminate improper practices of marketing of BMS that may undermine breastfeeding [32,33]. Many paediatric organisations support that no direct marketing to consumers should occur for infant formula and for follow-up formula for older infants, which are generally presented with similar brand names and design as infant formulae, because improper marketing may mislead families to perceive formula feeding as equivalent to breastfeeding and hence may undermine breastfeeding [34]. Similarly, paediatric organisations oppose marketing to consumers for formula for special medical purposes for infants (e.g., special formula for treating cow’s milk allergy, for preterm babies, etc.) because these should only be used upon medical advice and under medical supervision [3]. Therefore, also these products must not be promoted with any type of advertisement directed to parents, such as TV advertisements. Currently, the practice of marketing infant and follow-up formulae in many countries is still less than satisfactory. Paediatricians and their organisations, consumer organisations and governmental bodies should strengthen their joint efforts to end improper marketing practices.

7.1. Regulations on Marketing of Infant Formula

The framework for infant formula marketing regulation is the International Code of BMS; however, each country develops their national regulations and can determine standards for industry and the health care sector. The regulations of most countries are available online and were compiled for this review. Figure 2 shows the local current regulation available on line for Latin American countries.
One of the aspects that can be variable is the periodicity for updates. Table 6 and Table 7 provide an overview of the current legal scenario in Latin America and the most recent updates.
Among the divergent aspects in the various national regulations is the different emphasis on the use of local language, the inclusion of labelling aspects such as the cost of using the product for 6 months, the specific prohibition of messages that could lead to doubt of mothers about their capability to breastfeed, and prohibition of some types of illustrations such as animal forms or toys, and other topics such as safe feeding methods.
The existence of different regulations among countries may lead to problems in communication, and the creation of joint policies and protocols for the region, and may facilitate the perpetuation of breaches of the international code for BMS and continuation of inequity in infant health for specific countries.

7.2. New Marketing Strategies

With the surge of social media, a new space for novel marketing strategies has emerged. A new phenomenon appeared, the marketing by social media “influencers”. An influencer here is defined as a person who is paid by a company to describe and promote its products on social media and to encourage people to buy them [58]. With this and other strategies, the internet is now an important platform to marketing foods including foods for infants, exposing particularly young people that tend to use the internet at a considerable amount of time [59]. This concept is rather new and has not been consistently regulated. Often the payment of an influencer for promoting commercial products or services is not disclosed, and many followers may not be aware of the advertising character of messages that may be presented as personal experience and advice among friends.
BMS regulations in large parts of the world including Latin America prohibit advertisement of standard infant formula to the public. However, the influencer strategy is currently used to promote standard infant formulae and circumvents existing regulations. It is imperative for the International Code of BMS and national regulations to ban this kind of promotion in order to avoid that parents are unduly influenced, and that breastfeeding rates and duration are undermined.

7.3. The Role of Influencers

The American Academy of Pediatrics reported that many recommendations followed by mothers regarding infant and young child feeding practices are based on experience and personal recommendations [60] and not evidence-based [61] (Figure 3). Qualitative studies show that mothers more often are guided by recommendations from another mother rather than a health professional [62], influenced by an often-perceived lack of empathy from health professionals. This space has also been increasingly filled by different types of “influencers” using social media. More and more, marketing messages are shared by social media influencers worldwide, with little information available in the scientific literature addressing it. Here we describe the authors’ observations in social media in Latin America (specially Colombia and Mexico) and Europe (specially Germany). The first type of influencer is highly related to the perception of mothers of a lack of empathy from the health professionals. Influencers obtain information on infant feeding from various credible sources any may even use certification e.g., from Massive Online Open Courses (MOOC). Claiming the authority gained from this training, some produce educational material in different formats or styles (posts, short videos, live streaming, etc.) and share it on social media providing recommendations on different aspects of breastfeeding, bottle and complementary feeding that should only be provided by a health professional, and even promote specific products.
A second type of influencer is equally connected to the preference of mothers to take advice from another mother. Particularly effective are models that are providing these recommendations and are popular as actresses, singers or celebrities in general. Mothers with this profile can narrate their experience with pregnancy and feeding process for their infants on social media.
These messages are frequently indirectly linked to positive characteristics or emotions such as “empowerment“, which can be equivocal in this situation, especially if this represents a profit for the mother and companies find a place to promote products like formulae without even a disclosure of the paid publicity.
A third problematic scenario in this regard is the use of social media by health professionals. Using equivocal denominations for short trainings that could undermine the postgraduate degrees and lead to misinformation by the followers. Similarly, the production of recommendations that are not completely linked to their area of expertise.

8. Feeding and Infant Health

Exclusive feeding with human milk is consider the ideal feeding method during the first six months of life. Subsequently, adequate complementary feeding is of great importance since part of the calories and nutrient requirements are not met by human milk alone from the age of about 6 months onwards [62].
While during the first six months of age children’s’ health depends completely on the mother’s diet, after the introduction of different foods health will also depend on the foods that are provided to the child. An appropriate nutrition during the first 2 years of age and within the preschooler years (until 5 years of age) is fundamental due to its impact in different aspects of health and development [63]. The benefits of breastfeeding in the short term include a reduction in infectious disease and children mortality and in the long-term cognitive development the prevention of chronic health conditions such as obesity and diabetes in the future [63]. Complementary feeding and nutrition of the young child and preschooler years is also crucial due to the establishment of eating habits which are directly related to microbiota homeostasis which is accomplished by the age of three [64,65,66].
It has been described how the first 1000 days of life are determining for children Health and programming future health in the adult life. A period of even 2000 days has been proposed as being important for the establishment of gut microbiota. Table 8 describes the distribution of these first 2000 days of life.
However, in Latin America often time breastfeeding and complementary feeding recommendations are not met. In combination with other circumstances (often linked to poverty) such as the absence of clean potable water, inadequate hygienic or sanitation conditions, wrong preparation of infant formula, and other risk factors, considerable rates of preventable infant and young child morbidity and mortality due to infectious respiratory and gastrointestinal disease persist. A complex interaction results since malnutrition makes children more susceptible to infection, and infections lead to aggravate malnutrition by decreasing appetite, inducing catabolism, and increasing demand for nutrients [68].
According to UNICEF, diarrhea is a leading death cause of young children, accounting for approximately 8% of all deaths among children under age 5 worldwide in 2017. This translates to over 1400 young children dying each day, or about 525,000 children a year [69]. Pneumonia kills more children than any other infectious disease, claiming the lives of over 800,000 children under five every year, or around 2200 every day. Globally, there are over 1400 cases of pneumonia per 100,000 children, or 1 case per 71 children every year [70]. Recommended preventive strategies for both these conditions include the promotion of adequate nutrition for mothers and children, breastfeeding promotion and support, vaccination, micronutrient supplementation (such as zinc, vitamin A), hand washing with soap, and the prevention and treatment of co-morbidities (such as HIV) [71].

9. Conclusions

Breastfeeding is the ideal feeding method for infants. BMS supplement or replace human milk when it is available in sufficient amounts, but do not provide the same benefits of breastfeeding such as prevention of infectious diseases, promotion of cognitive development, mother infant bonding, and risk reduction of maternal diseases. Follow-up formulae are marketed for the changing needs of the infant. Young child formulae can have a special advantage when used for children with a poor dietary quality. For all these products a correct preparation and hygienic conditions are of key importance. The regulation for marketing of infant formulae varies among different countries in Latin America. Among the aspects that differ are the specification for the use of local language, and the degree of prohibition of specific messaging or illustrations. Social media influencers are an increasingly important source of information on infant feeding decision for families, and they often implement marketing of commercial products against payment, which often is not transparently disclosed, circumventing established restrictions on the marketing of BMS. Three types of influencers that induce risk include mothers who took short trainings on infant feeding, the use of celebrities to promote products or feeding practices, and health professionals who use equivocal denomination for their professional training on social media. Responsibility for these worrying developments lies not only with individual influencers, but to a large extent with the commercial powers who provide financial incentives to them for marketing products. There is an urgent need for stakeholders such as governmental bodies, health care professionals and their associations, and parent and consumer organizations to jointly put pressure on infant food manufacturers to end such inappropriate marketing practices.

Author Contributions

Conceptualization, L.L. and B.K.; methodology, L.L. and R.V.-F.; formal analysis, B.K., L.L. and R.V.-F.; investigation, L.L. and N.S.; resources, L.L. and N.S.; writing—original draft preparation, N.S.; writing—review and editing, L.L., B.K., R.V.-F. and N.S. All authors have read and agreed to the published version of the manuscript.


This research received no external funding.

Conflicts of Interest

L.L. has received research grants from Nestlé Nutrition Institute, speaker honorarium from Abbott, Pfizer, Nutricia, Mead Johnson, Nestlé, Actelion and Biomarin and has been involved as a consultant in Reckitt Benckiser. N.S. declare no conflict of interest. R.V.-F. has received research grants from Sanofi, speaker honorarium from Abbott pharmaceutical, BioGaia, Nestlé, Nestle Nutrition Institute and Sanofi. B.K. tends to be biased towards breastfeeding as member of the German National Breastfeeding Committee, chair of the Nutrition Committee, German Paediatric Society, and President, International Society for Research in Human Milk and Lactation. B.K. is the Else Kröner-Senior professor of Pediatrics co-funded by the Else Kröner-Fresenius-Foundation.


  1. World Health Organization. Essential Nutrition Actions: Improving Maternal, Newborn, Infant and Young Child Health and Nutrition; WHO: Geneva, Switzerland, 2013. [Google Scholar]
  2. European Food Safety Authority (EFSA). Scientific Panel on Nutrition, Novel Foods and Food allergen. In Minutes of the 43rd Meeting of the Working Group on Food Allergies; EFSA: Parma, Italy, 2019. [Google Scholar]
  3. Koletzko, B. Formula Feeding. World Rev. Nutr. Diet. 2015, 113, 97–103. [Google Scholar] [CrossRef]
  4. Codex Alimentarius Commission. Standard for Infant Formulas and Formulas for Medical PURPOSES Intended for Infants; Report No.: CXS 72–1981; Codex Alimentarius Commission: Rome, Italy, 2007. [Google Scholar]
  5. European Food Safety Authority (EFSA). Scientific Opinion on the Essential Composition of Infant and Follow-On Formulae; EFSA: Parma, Italy, 2014. [Google Scholar]
  6. European Union. Commission Delegated Regulation (EU) 2016/127 of 25 September 2015 Supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as Regards the Specific Compositional and Information Requirements for Infant Formula and Follow-On Formula and as Regards Requirements on Information Relating to Infant and Young Child Feeding; Official Journal of the European Union; European Union: Maastricht, The Netherlands, 2016; p. L25. [Google Scholar]
  7. Federal Food and Drugs Administration. CA4T2. Code of Federal Regulations; Federal Food and Drugs Administration: Silver Spring, MD, USA, 2014; pp. 106–107.
  8. American Academy of Pediatrics Committee on Nutrition. Formula Feeding of Term Infants. In Pediatric Nutrition, 8th ed.; Kleinman, R.E., Ed.; American Academy of Pediatrics Committee on Nutrition: Itasca, IL, USA, 2019; pp. 79–104. [Google Scholar]
  9. Koletzko, B.; Baker, S.; Cleghorn, G.; Neto, U.F.; Gopalan, S.; Hernell, O.; Hock, Q.S.; Jirapinyo, P.; Lonnerdal, B.; Pencharz, P.; et al. Global standard for the composition of infant formula: Recommendations of an ESPGHAN coordinated international expert group. J. Pediatr. Gastroenterol. Nutr. 2005, 41, 584–599. [Google Scholar] [CrossRef] [PubMed][Green Version]
  10. Koletzko, B.; Demmelmair, H.; Grote, V.; Totzauer, M. Optimized protein intakes in term infants support physiological growth and promote long-term health. Semin. Perinatol. 2019, 43, 151153. [Google Scholar] [CrossRef] [PubMed]
  11. Weber, M.; Grote, V.; Closa-Monasterolo, R.; Escribano, J.; Langhendries, J.P.; Dain, E.; Giovannini, M.; Verduci, E.; Gruszfeld, D.; Socha, P.; et al. Lower protein content in infant formula reduces BMI and obesity risk at school age: Follow-up of a randomized trial. Am. J. Clin. Nutr. 2014, 99, 1041–1051. [Google Scholar] [CrossRef]
  12. Francavilla, R.; Calasso, M.; Calace, L.; Siragusa, S.; Ndagijimana, M.; Vernocchi, P.; Brunetti, L.; Mancino, G.; Tedeschi, G.; Guerzoni, E.; et al. Effect of lactose on gut microbiota and metabolome of infants with cow’s milk allergy. Pediatric Allergy Immunol. 2012, 23, 420–427. [Google Scholar] [CrossRef]
  13. Szlagyi, A. Review article: Lactose—A potential prebiotic. Aliment. Pharmacol. Ther. 2002, 16, 1591–1602. [Google Scholar] [CrossRef]
  14. Koletzko, B. Human Milk Lipids. Ann. Nutr. Metab. 2016, 69 (Suppl. 2), 28–40. [Google Scholar] [CrossRef][Green Version]
  15. Koletzko, B.; Bergmann, K.; Brenna, J.T.; Calder, P.C.; Campoy, C.; Clandinin, M.T.; Colombo, J.; Daly, M.; Decsi, T.; Demmelmair, H.; et al. Should formula for infants provide arachidonic acid along with DHA? A position paper of the European Academy of Paediatrics and the Child Health Foundation. Am. J. Clin. Nutr. 2020, 111, 10–16. [Google Scholar] [PubMed]
  16. Koletzko, B.V.; Shamir, R. Infant formula: Does one size fit all? Curr. Opin. Clin. Nutr. Metab. Care 2016, 19, 205–207. [Google Scholar] [CrossRef] [PubMed]
  17. Codex Alimentarius. CODEX Standard Follow-Up Formula 156–1987; Codex Alimentarius: Berlin, Germany, 2013; pp. 1–44. Available online: (accessed on 3 May 2021).
  18. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Turck, D.; Bresson, J.L.; Burlingame, B.; Dean, T.; Fairweather-Tait, S.; Heinonen, M.; Hirsch-Ernst, K.I.; Mangelsdorf, I.; McArdle, H.J.; et al. Scientific Opinion on the safety and suitability for use by infants of follow-on formulae with a protein content of at least 1.6 g/100 kcal. EFSA J. 2017, 11, 15. [Google Scholar]
  19. Koletzko, B. Why breastfeeding? In Breastfeeding and Breast Milk—From Biochemistry to Impact. Stuttgart, Family-Larsson-Rosenquist-Foundation; Thieme: New York, NY, USA, 2018; pp. 78–89. [Google Scholar]
  20. Koletzko, B.; Bhutta, Z.A.; Cai, W.; Cruchet, S.; El Guindi, M.; Fuchs, G.J.; Goddard, E.A.; van Goudoever, J.B.; Quak, S.H.; Kulkarni, B.; et al. Compositional requirements of follow-up formula for use in infancy: Recommendations of an international expert group coordinated by the Early Nutrition Academy. Ann. Nutr. Metab. 2013, 62, 44–54. [Google Scholar] [CrossRef] [PubMed][Green Version]
  21. Suthutvoravut, U.; Abiodun, P.O.; Chomtho, S.; Chongviriyaphan, N.; Cruchet, S.; Davies, P.S.; Fuchs, G.J.; Gopalan, S.; van Goudoever, J.B.; Nel Ede, L.; et al. Composition of Follow-Up Formula for Young Children Aged 12–36 Months: Recommendations of an International Expert Group Coordinated by the Nutrition Association of Thailand and the Early Nutrition Academy. Ann. Nutr. Metab. 2015, 67, 119–132. [Google Scholar] [CrossRef] [PubMed][Green Version]
  22. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on nutrient requirements and dietary intakes of infants and young children in the European Union. EFSA J. 2013, 11, 3408. [Google Scholar]
  23. Hojsak, I.; Bronsky, J.; Campoy, C.; Domellöf, M.; Embleton, N.; Fidler Mis, N.; Hulst, J.; Indrio, F.; Lapillonne, A.; Mølgaard, C.; et al. Young Child Formula: A Position Paper by the ESPGHAN Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 2018, 66, 177–185. [Google Scholar] [CrossRef]
  24. UNICEF. From the First Hour of Life; UNICEF: New York, NY, USA, 2016. [Google Scholar]
  25. Dipasquale, V.; Serra, G.; Corsello, G.; Romano, C. Standard and Specialized Infant Formulas in Europe: Making, Marketing, and Health Outcomes. Nutr. Clin. Pract. 2020, 35, 273–281. [Google Scholar] [CrossRef]
  26. World Health Organization; Food and Agriculture Organization of the United Nations. Safe Preparation, Storage and Handling of Powdered Infant Formula Guidelines; World Health Organization: Geneva, Switzerland, 2007. [Google Scholar]
  27. FAO-OMS; Organización de las Naciones Unidas para la Agricultura y la Alimentación. Directrices, Preparación, Almacenamiento y Manipulación en Condiciones Higiénicas de Sucedáneos en Polvo para Lactantes en Entornos Asistenciales; OMS Ediciones: Geneva, Switzerland, 2007. [Google Scholar]
  28. Luque, V.; Escribano, J.; Mendez-Riera, G.; Schiess, S.; Koletzko, B.; Verduci, E.; Stolarczyk, A.; Martin, F.; Closa-Monasterolo, R. Methodological approaches for dietary intake assessment in formula-fed infants. J. Pediatr. Gastroenterol. Nutr. 2013, 56, 320–327. [Google Scholar] [CrossRef][Green Version]
  29. Márquez, M.; Ladino, L. Menos polvo, más volumen: Reducción en los costos de preparación de las fórmulas lácteas infantiles de inicio. Rev. Salud Bosque 2017, 7, 43–48. [Google Scholar] [CrossRef][Green Version]
  30. Ladino, L.; Velásquez, O. Características e Indicaciones de las Fórmulas Lácteas. In Nutridatos Manual de Nutrición Clínica, 3rd ed.; Health Book’s: Medellín, Colombia, 2021; pp. 283–296. [Google Scholar]
  31. Agostoni, C.; Axelsson, I.; Goulet, O.; Koletzko, B.; Michaelsen, K.F.; Puntis, J.W.; Rigo, J.; Shamir, R.; Szajewska, H.; Turck, D.; et al. Preparation and handling of powdered infant formula: A commentary by the ESPGHAN Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 2004, 39, 320–322. [Google Scholar] [CrossRef] [PubMed]
  32. World-Health-Assembly. WHA Resolution 34.22. International Code of Marketing of Breast-Milk Substitutes; World Health Organisation: Geneva, Switzerland, 1981. [Google Scholar]
  33. World Health Organization. The International Code of Marketing of Breast-Milk Substitutes: Frequently Asked Questions on the Roles and Responsibilities of Health Workers; World Health Organization: Geneva, Switzerland, 2020. [Google Scholar]
  34. Bognar, Z.; De Luca, D.; Domellöf, M.; Hadjipanayis, A.; Haffner, D.; Johnson, M.; Kolacek, S.; Koletzko, B.; Saenz de Pipaon, M.; Shingadia, D.; et al. Promoting Breastfeeding and Interaction of Pediatric Associations with Providers of Nutritional Products. Front. Pediatr. 2020, 25, 562870. [Google Scholar] [CrossRef]
  35. Ministerio de Salud Pública de Ecuador. Ley 101/1995 Ley de Fomento Apoyo y Protección a la lactancia Materna. Available online: (accessed on 5 May 2021).
  36. SITEAL UNESCO. Decreto Supremo 009/2006, Reglamento de Alimendación Infantil. Available online: (accessed on 5 May 2021).
  37. Invima. Decreto Número 1397 de 1992. Available online:–8f83-fd2a05ca5b54 (accessed on 5 May 2021).
  38. Ministerio de Salud de Nicaragua. Ley 295 Ley de Promoción, Protección y Mantenimiento de la Lactancia Materna y Regulación de la Comercialización de Sucedáneos de la Leche Materna. Available online: (accessed on 5 May 2021).
  39. República de Panamá Órgano Judicial. Ley No. 50 del 23 de Noviembre de 1995 Protege y Fomenta la Lactancia Materna. Available online: (accessed on 5 May 2021).
  40. World Health Organization. Policy Decreto Ejecutivo No.1457 (de 30 de Octubre de 2012) que Reglamenta la Ley No.50 de 23 de Noviembre de 1995, por la cual se Protege y Fomenta la Lactancia Materna. Available online: (accessed on 5 May 2021).
  41. Diario Oficial de la Federación de México. Proyecto de Norma Oficial Méxicana 050/2018 del 2 de Mayo. Available online: (accessed on 5 May 2021).
  42. Gobierno de México. NORMA Oficial Mexicana NOM-131-SSA1-2012, Productos y Servicios. Fórmulas para Lactantes, de Continuación y para Necesidades Especiales de Nutrición. Alimentos y Bebidas no Alcohólicas para Lactantes y Niños de Corta Edad. Disposiciones y Especificaciones Sanitarias y Nutrimentales. Etiquetado y Métodos de Prueba. Available online: (accessed on 5 May 2021).
  43. SITEAL UNESCO. Ley Nº 8 (y su Decreto Reglamentario Nº 31/1996)/1995. Declara Como Prioridad Nacional la Promoción y Fomento de la Lactancia Materna. Available online: (accessed on 5 May 2021).
  44. Reglamento para Aplicación de la ley que Declara Como Prioridad Nacional la Promoción y Fomento de la Lactancia Materna. Available online: (accessed on 5 May 2021).
  45. Gobierno de Argentina. Código Alimentario Argentino Capítulo XVIII Alimentos de Regimen o Dietéticos. Available online: (accessed on 5 May 2021).
  46. Argentina. Ley 26.873/2013 del 5 de Agosto, Lactancia Materna Promoción y Conscientización Pública. Available online: (accessed on 5 May 2021).
  47. Biblioteca del Congreso Nacional de Chile. Decreto 977 Aprueba Reglamento Sanitario de Alimentos, Titulo XXVIII De los Alimentos para Regímenes Especiales, Párrafo II, Artículo 497. Available online: (accessed on 5 May 2021).
  48. Biblioteca del Congreso Nacional de Chile. Ley 21155 Establece Medidas de Protección a la Lactancia Materna y su Ejercicio. Available online: (accessed on 5 May 2021).
  49. Observatorio de Igualdad de Género CEPAL. Ley de Fomento a la Lactancia Materna y Comercialización de sus Sucedáneos. Available online: (accessed on 5 May 2021).
  50. Legal Office FAO LEX. Ley de Comercialiacion de los Sucedaneos de la Leche Materna y su Reglamento Decreto ley Numero 66–83. Available online: (accessed on 5 May 2021).
  51. SITEAL UNESCO. Decreto Legislativo Nº 404/2013. Ley de Promoción, Protección y Apoyo a la Lactancia Materna. Available online: (accessed on 5 May 2021).
  52. Biblioteca de Archivo Central del Congreso de la Nación. Ley Nº 1478/Comercialización de Sucedáneos de la Leche Materna. Available online: (accessed on 5 May 2021).
  53. Ministerio de Salud de Costa Rica. Ley 7430 de Fomento a la Lactancia Materna. Available online: (accessed on 5 May 2021).
  54. SITEAL UNESCO. Decreto 231/2013 Ley de Fomento y Protección a la Lactancia Materna. Available online: (accessed on 5 May 2021).
  55. Planalto. Decreto nº 9.579 de Novembro, do Lactente, da Criança e do Adolescente e do Aprendiz, e Sobre o Conselho Nacional dos Direitos da Criança e do Adolescente, o Fundo Nacional para a Criança e o Adolescente e os Programas Federais da Criança e do Adolescente, e dá Outras Providências. Available online: (accessed on 27 May 2021).
  56. República Bolivariana de Venezuela. Ley de Promocion, Protección y Apoyo a la Lactancia Materna/2007 del 12 de Julio. Available online: (accessed on 5 May 2021).
  57. Comisión de Salud Pública y Asistencia Social Repartido nº 702 Junio de 2017 Carpeta nº 2062 de 2017 Comercialización de Sucedáneos de Leche Materna. Available online: (accessed on 27 May 2021).
  58. Oxford Dictionary. Influencer. Available online: (accessed on 5 May 2021).
  59. Coates, A.E.; Hardman, C.A.; Halford, J.C.G.; Christiansen, P.; Boyland, E.J. Social Media Influencer Marketing and Children’s Food Intake: A Randomized Trial. Pediatrics 2019, 143, e20182554. [Google Scholar] [CrossRef][Green Version]
  60. American Academy of Pediatrics Committee on Nutrition. Complementary Feeding. In Pediatric Nutrition, 7th ed.; Kleinman, R.E., Greer, F.R., Eds.; American Academy of Pediatrics: Itasca, IL, USA, 2013; pp. 123–134. [Google Scholar]
  61. McInnes, R.J.; Chambers, J.A. Supporting breastfeeding mothers: Qualitative synthesis. J Adv Nurs. 2008, 62, 407–427. [Google Scholar] [CrossRef] [PubMed]
  62. WHO. Complementary Feeding. Available online: (accessed on 15 July 2021).
  63. The Long-Term Effects of Breastfeeding: A Systematic Review; World Health Organization: Geneva, Switzerland, 2013.
  64. Fan, Y.; Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 2021, 19, 55–71. [Google Scholar] [CrossRef]
  65. Chen, L.; Garmaeva, S.; Zhernakova, A.; Fu, J.; Wijmenga, C. A system biology perspective on environment-host-microbe interactions. Hum. Mol. Genet. 2018, 27, R187–R194. [Google Scholar] [CrossRef] [PubMed][Green Version]
  66. Fewtrell, M.; Bronsky, J.; Campoy, C.; Domellöf, M.; Embleton, N.; Fidler Mis, N.; Hojsak, I.; Hulst, J.M.; Indrio, F.; Lapillonne, A.; et al. Complementary Feeding: A Position Paper by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 2017, 64, 119–132. [Google Scholar] [CrossRef] [PubMed]
  67. Ladino, L. Nutrición Desde la Preconcepción Hasta la Etapa Preescolar. In Alimentación y Nutrición Aplicada; Rodríguez, G., Ed.; Editorial Universidad El Bosque: Bogotá, Colombia, 2018; pp. 406–421. Available online: (accessed on 5 May 2021).
  68. Rytter, M.J.H.; Kolte, L.; Briend, A.; Friis, H.; Christensen, V.B. The Immune System in Children with Malnutrition—A Systematic Review. PLoS ONE 2014, 9, e105017. [Google Scholar] [CrossRef][Green Version]
  69. UNICEF DATA. Diarrhoea. 2021. Available online: (accessed on 15 July 2021).
  70. UNICEF DATA. Pneumonia. 2021. Available online: (accessed on 15 July 2021).
  71. UNICEF. Pneumonia and Diarrhoea Tackling the Deadliest Diseases for the World’s Poorest Children; UNICEF: New York, NY, USA, 2012. [Google Scholar]
Figure 1. Average energy and minimum protein content of formulae targeting different age groups. Author’s creation, 2021.
Figure 1. Average energy and minimum protein content of formulae targeting different age groups. Author’s creation, 2021.
Nutrients 13 03942 g001
Figure 2. National regulations on infant formula marketing in Latin America available or not available online. Author’s creation, 2021.
Figure 2. National regulations on infant formula marketing in Latin America available or not available online. Author’s creation, 2021.
Nutrients 13 03942 g002
Figure 3. Causes, consequences and actors involved with influencer mothers.
Figure 3. Causes, consequences and actors involved with influencer mothers.
Nutrients 13 03942 g003
Table 1. Recommendation on the composition of infant formulae by an international expert group coordinated by the ESPGHAN [9].
Table 1. Recommendation on the composition of infant formulae by an international expert group coordinated by the ESPGHAN [9].
Energy kcal/100 mL6070
Proteins g/100 kcal
Cow’s milk protein1.83
Soy protein isolates2.253
Hydrolyzed cow’s milk protein1.83
Total fat, g/100 kcal4.46
Linoleic acid, g/100 kcal0.31.2
α-Linolenic acid, mg/100 kcal50n.s.
Ratio linoleic/α-Linolenic acids5:115:1
Lauric + myristic acids, % of fatn.s.20
Trans fatty acids, % of fatn.s.3
Erucic acids, % of fatn.s.1
Total carbohydrates, g/100 kcal914
Vitamin A, µg RE/100 kcal60180
Vitamin D3, µg/100 kcal12.5
Vitamin E, mg α-TE/100 kcal0.55
Vitamin K, µg/100 kcal425
Thiamin, µg/100 kcal60300
Riboflavin, µg/100 kcal80400
Niacin, µg/100 kcal3001,500
Vitamin B6, µg/100 kcal35175
Vitamin B12, µg/100 kcal0.10.5
Pantothenic acid, µg/100 kcal4002,000
Folic acid, µg/100 kcal1050
Vitamin C, mg/100 kcal1030
Biotin, µg/100 kcal1.57.5
Mineral trace elements
Iron (formula based on cow’s milk protein and protein hydrolysate mg/100 kcal)0.31.3
Iron (formula based on soy protein isolate) mg/100 kcal0.452
Calcium mg/100 kcal50140
Phosphorus (formula based on cow’s milk protein and protein hydrolysate, mg/100 kcal)2590
Phosphorus (formula based on soy protein isolate) mg/100 kcal30100
Ratio calcium/phosphorus mg/mg1:12:1
Magnesium mg/100 kcal515
Sodium mg/100 kcal2060
Chloride mg/100 kcal50160
Potassium mg/100 kcal60160
Manganese µg/100 kcal150
Fluoride µg/100 kcaln.s.60
Iodine µg/100 kcal1050
Selenium µg/100 kcal19
Copper µg/100 kcal3580
Zinc mg/100 kcal0.51.5
Other substances
Choline mg/100 kcal750
Myo-inositol mg/100 kcal440
L-Carnitine mg/100 kcal1.2n.s.
Table 2. Compositional requirements for infant formula based on cows’ milk proteins.
Table 2. Compositional requirements for infant formula based on cows’ milk proteins.
100 mL100 Kcal
Protein g1.1–2.11.8–3.0
Fat g2.6–4.24.4–6.0
Carbohydrates g5.4–9.89.0–14.0
Table 3. Recommended composition of follow-up formula for older infants by an international expert group coordinated by the Early Nutrition Academy [20].
Table 3. Recommended composition of follow-up formula for older infants by an international expert group coordinated by the Early Nutrition Academy [20].
Component/UnitMinimumMaximumGuidance Upper Level
Energy kcal/100 mL6070
Cow’s milk protein g/100 kcal1.72.5
Soy protein isolates g/100 kcal2.12.5
Total fat, g/100 kcal4.46.0
Linoleic acid, g/100 kcal0.3 1.4
α-Linolenic acid, mg/100 kcal50n.s.
Ratio linoleic/α-Linolenic acids5:115:1
Lauric + myristic acids, % of fatn.s.20
Trans fatty acids, % of fatn.s.3
Erucic acids, % of fatn.s.1
Phospholipids mg/100 kcal 550
Total carbohydrates914
Vitamin A, µg RE/100 kcal60180
Vitamin D3, µg/100 kcal14.5
Vitamin E, mg α-TE/100 kcal0.5 5
Vitamin K, µg/100 kcal4 27
Thiamin, µg/100 kcal60 300
Riboflavin, µg/100 kcal80 500
Niacin, µg/100 kcal300 1,500
Vitamin B6, µg/100 kcal35 175
Vitamin B12, µg/100 kcal0.1 1.5
Folic acid, µg/100 kcal10 50
Pantothenic acid, µg/100 kcal400 2000
Vitamin C, mg/100 kcal10 70
Biotin, µg/100 kcal1.5 10
Minerals and trace elements
Iron (formula based on cow’s milk protein), mg/100 kcal1.11.9
Iron (formula based on soy protein isolates), mg/100 kcal1.32.5
Calcium, mg/100 kcal50 180
Phosphorus, mg/100 kcal25 n.s.
Magnesium, mg/100 kcal5 15
Sodium, mg/100 kcal20 60
Chloride, mg/100 kcal50 160
Potassium, mg/100 kcal60 180
Manganese, µg/100 kcal 100
Iodine, µg/100 kcal10 60
Selenium, µg/100 kcal1 9
Copper, µg/100 kcal35 250
Zinc, mg/100 kcal0.5 1.5
Other substances
Choline, mg/100 kcal7 150
L-Carnitine, mg/100 kcal1.2n.s.
Taurine, mg/100 kcaln.s.12
Total added nucleotides, mg/100 kcal0 10.8
Table 4. Compositional requirements of young child formula for young children aged 12–36 months proposed by an International Expert Group co-ordinated by the Nutrition Association of Thailand and the Early Nutrition Academy. Modified from [21].
Table 4. Compositional requirements of young child formula for young children aged 12–36 months proposed by an International Expert Group co-ordinated by the Nutrition Association of Thailand and the Early Nutrition Academy. Modified from [21].
ComponentMinimumMaximumGuidance Upper Level
Energy, kcal/100 mL4570
Proteins g/100 kcal
Cow’s milk protein, g/100 kcal1.62.7
Soy protein isolate, g/100 kcal22.7
Total fat. g/100 kcal4.46.0
Linoleic acid, mg/100 kcal500NS
Alpha-linolenic acid, mg/100 kcal50NS
Trans fatty acids, % of fatNS2
DHA 1, % of fat0.3NS
Total carbohydrates, g/100 kcal914
Vitamin A 2, mcg RE/100 kcal60 180
Vitamin D, mcg/100 kcal1.5 4.5
Vitamin B12, mcg/100 kcal0.15 0.75
Folic acid, mcg/100 kcal20 100
Vitamin C, mg/100 kcal4.5 22.5
Minerals and trace elements
Iron 3 (formula based on cow’s milk protein), mg/100 kcal1 3
Iron (formula based on soy protein isolates), mg/100 kcalNS NS
Calcium, mg/100 kcal200 NS
Sodium, mg/100 kcal25 75
Iodine, mcg/100 kcal12 36
Zinc, mg/100 kcal0.6 1.8
NS, Not specified; DHA, Docosahexaenoic acid. 1 The addition of DHA is optional. 2 1 mcg RE (retinol equivalent) = 1 mcg all-trans retinol = 3.33 IU vitamin A. Retinol contents shall be provided by preformed retinol, while any contents of carotenoids should not be included in the calculation and declaration of vitamin A activity. 3 The bioavailability is approximately 10%.
Table 5. Concentration and Final Volume of Properly Prepared Formulae. Modified from [30].
Table 5. Concentration and Final Volume of Properly Prepared Formulae. Modified from [30].
Water (mL/ounces) Powder (g)Displaced Water (mL *)Final Volume (mL)Powder Energy (kcal)
30/14.33.333 22
* Considering that 1 g of powder displaces 0.77 mL and that they are concentrated at 13%, so they provide 0.67 kcal/mL (≈20 kcal/ounce).
Table 6. Regulations on BMS in Latin American countries.
Table 6. Regulations on BMS in Latin American countries.
CountryYearName and NumberInstitution
Ecuador [35]1995Law 101, Official Register No. 814Health Ministry
Perú [36]2006Supreme Decrete N 009Health Ministry
Colombia [37]1992Decrete 1397Health Ministry
Nicaragua [38]1999Law 295Health Ministry
Panamá [39,40]1995
Law 50
Decrete 1457
Health Ministry
Estados de Unidos de México [41,42]2012
Bill 050
Executive power
Health Secretary
República Dominicana [43,44]1996
Law No 8
Decrete 31
Congress of the republic
Congress of the republic
Argentina [45,46]2013
Law 26.873
National Law 18284
Public Health Secretary
Chile [47,48]1996
Decrete 977
Law 21155
Health Ministry
Ministry of woman and gender equity
Bolivia [49]2006Law 3460Congress
Guatemala [50]1983Law 66–83Health and social assistance Ministry
El Salvador [51]2013Decrete 404Legislative branch
Paraguay [52]1999Law 1.478Congress
Costa Rica [53]1995Law 7430Health Ministry
Honduras [54]2013Decrete 231Congress
Brazil [55]2018Decrete Nº 9.579Executive branch
Venezuela [56]2007Law for protection, promotion and support of breastfeedingNational assembly
Permanent commision for family, woman and youth
Uruguay [57]2017File 2062House of representatives
Table 7. Items related to BMS regulated in different Latin American countries.
Table 7. Items related to BMS regulated in different Latin American countries.
CountryLabel: State Human Milk Is Superior and the Ideal Feeding OptionLabel: State Proper Manipulation, Storage and PreparationLabel: State Risk of Inappropriate Preparation or Non-Hygienic ConditionsLabel: Pictures or Graph That Suggest Formula Is an Ideal Feeding MethodLabel: Forbids the Use of the Terms Humanized or Maternalized MilksLabel: Forbids the Use of Pictures of Children, Feeding Bottles, Toys or Animals (Except for Preparation Directions)Label: Official Language and Native Language AdaptationsLabel: Logo or Brand Name <20% of Space in LabelLabel: It Should Only Be Used under Medical PrescriptionApproximate Cost for Using the Product for 6 MonthsLabel: Risks for Using Feeding BottlesLabel: Describing Best Way to Feed (Cup, Spoon)
Ecuador [35]XXXXXXX---------------
Perú [36]XX---XXXX---------------
Colombia [37]XXXXXX---------------X
Nicaragua [38]XXXXXXX---------------
Panamá [39,40]XX ---XXXXX---------
Estados de Unidos de México [41,42]XXXXX---------X---------
República Dominicana [43,44]XXXXXXX---XXX---
Argentina [45,46]XXXXXXX---X---------
Chile [47,48]XX---XXX--------X---------
Bolivia [49]XX---XXXX------X------
Guatemala [50]XX---XXX------------------
El Salvador [51]---------XXXX---------------
Paraguay [52]XXRisk of feeding wrong age group---X---X---------------
Costa Rica [53]XXXXXXX---X---------
Honduras [54]XXXXXX------------------
Brazil [55]XXXXXX------X---------
Venezuela [56]XXXXXXX---X------X
Uruguay [57]XXXXXXX---XXX---
The X in the table means this aspect is included in the local norm for BMS regulation.
Table 8. Nutrition during the First 2000 days distribution.
Table 8. Nutrition during the First 2000 days distribution.
Pre-pregnancy500 days
Pregnancy270 days
First two years of age730 days
Preschooler years500 days
Based on Ladino L, 2018 [67].
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Back to TopTop